Background: Vitamin D modulates innate and adaptive immunity and has been investigated for preventing pediatric respiratory infections. Objective: To assess the effects of vitamin D supplementation on respiratory tract infections (RTIs), including upper RTIs, lower RTIs/recurrent pneumonia, and hospitalization/clinical severity in children and adolescents. Methods: Systematic review and random-effects meta-analysis of 16 publications, of which 13 contributed to quantitative synthesis. Twenty-four effect estimates were pooled, eight per outcome. The odds ratio (OR) was analyzed on its natural logarithmic scale (logOR), using restricted maximum likelihood (REML) estimation and Knapp-Hartung (KH) adjusted inference. Where necessary, risk ratios (RRs), hazard ratios (HRs), and incidence rate ratios (IRRs) were approximated on the logOR scale. Results: For respiratory infection/upper RTI, pooled logOR was −0.284 (KH-adjusted 95% confidence interval [CI]: −0.678 to 0.110; OR 0.753; p = 0.132; I 2 = 97.2%). For lower RTI/recurrent pneumonia, logOR was −0.445 (95% CI: −0.987 to 0.097; OR 0.641; p = 0.093; I 2 = 89.5%). For hospitalization/clinical severity, logOR was −0.609 (95% CI: −1.134 to −0.083; OR 0.544; p = 0.029; I 2 = 78.3%). Conclusions: Pooled estimates favored supplementation in direction for all three groups, although confidence intervals included the null for the first two. Heterogeneity was substantial, and the results are limited by approximations among effect measures, clinically diverse endpoints, and potentially correlated effects from individual studies.
Background: Vitamin B12 is essential for one-carbon metabolism, deoxyribonucleic acid (DNA) synthesis, and myelination, and inadequate maternal status during pregnancy may influence fetal growth and child neurodevelopment. Objective: To evaluate the association between maternal vitamin B12 status and perinatal and child neurodevelopmental outcomes. Methods: We conducted a systematic review and meta-analysis of observational studies and randomized clinical trials. The main outcomes were preterm birth, low birth weight, small for gestational age (SGA), and cognitive/global development. For binary outcomes, the natural logarithm of the relative risk (logRR) was the primary analytical effect measure; for neurodevelopment, Hedges g was used. Random-effects models were fitted, between-study variance was estimated by restricted maximum likelihood (REML), and inference used Knapp-Hartung (KH) adjustment. Results: For preterm birth, nine estimates yielded a pooled logRR of 0.190 (95% confidence interval [95% CI] KH: –0.046 to 0.427; p = 0.101; I2 = 19.2%). For low birth weight, nine estimates yielded a pooled logRR of 0.136 (95% CI KH: –0.013 to 0.286; p = 0.069; I2 = 4.8%). For SGA, six estimates yielded a pooled logRR of 0.047 (95% CI KH: –0.083 to 0.177; p = 0.397; I2 = 0%). Cognitive/global development, assessed in five independent studies, showed a pooled Hedges g of 0.266 (95% CI KH: 0.034 to 0.499; p = 0.034; I2 = 55.7%). Conclusions: logRR estimates for preterm birth and low birth weight were directionally compatible with higher risk among mothers with lower vitamin B12 availability, but their 95% CIs included the null. No consistent association was observed for SGA. Higher maternal vitamin B12 availability or supplementation was associated with a small favorable effect on cognitive/global development, with moderate heterogeneity.
Introduction: Growth hormone (GH) plays a key role in metabolic adaptation to fasting by stimulating lipolysis and preserving lean mass. However, there is no consensus on the magnitude of the GH response to short-term fasting in healthy adults. Objective: To systematically review the literature on the effect of 24-48 hour fasting on GH levels in healthy adults. Methods: A search was conducted in PubMed, Google Scholar, and Science Direct (2000-2025). Original studies with healthy adults undergoing 24-48h fasting and measuring GH as an outcome were included. A narrative synthesis was performed due to study heterogeneity. Results: Six studies (n=119 participants) were included. Twenty-four-hour fasting increased GH by 3-5 fold, without IGF-1 elevation (hepatic resistance). Prolonged fasting (≥36h) intensified the response, increasing GH pulse frequency and amplitude. The GH increase was associated with decreased insulin and leptin, stimulating lipolysis. Individuals with low basal GH showed greater relative increases. Discussion: Twenty-four to forty-eight-hour fasting significantly increases GH secretion in healthy adults, with a more pronounced response during prolonged fasting and in individuals with low basal GH. The GH-IGF-1 dissociation suggests adaptive hepatic resistance.
Constitutional Delay of Growth and Puberty (CDGP) is the most common cause of delayed puberty and a prevalent complaint in pediatric endocrinology, often associated with short stature in adolescence. This systematic review and meta-analysis aimed to synthesize the available evidence to estimate the prevalence of CDGP in this population. Following PRISMA guidelines, searches were conducted across multiple databases with no initial date restriction. Observational studies reporting the proportion of CDGP in adolescents with short stature were included. The quantitative synthesis used a random-effects model. Ten studies, totaling 1,516 participants, met the criteria. The pooled prevalence of delayed puberty was 69.7% (95% CI: 23.8% to 94.4%). However, heterogeneity among studies was extremely high (I² = 98.5%), and the confidence interval is wide, reflecting substantial uncertainty. Subgroup analyses indicated that age range, diagnostic criteria, and, most importantly, selection bias in referral settings are the main sources of this variation. It is concluded that the reported prevalence of CDGP is highly variable and contingent on clinical context and methodological definitions, not representing a robust population estimate. Future studies with standardized criteria and more diverse populations are needed.
This systematic review compared the efficacy of injectable versus transdermal testosterone inincreasing lean body mass (LBM) in adult men with hypogonadism over 12 weeks. An analysisof five studies, including clinical trials, revealed that both formulations significantly increaseLBM. However, injectable testosterone (enanthate/cypionate) demonstrated potentially greaterpotency and superior absolute gains, attributed to its supraphysiological serum peaks. Incontrast, transdermal testosterone (gel) provided a more predictable, dose-dependent, and stableincrease in LBM, with a favorable tolerability profile despite the risk of skin irritation. Theevidence suggests that injectable testosterone may be more effective for maximizing muscleanabolism in the short term, while the transdermal route offers superior hormonal stability.Therefore, the choice of therapy should be individualized, balancing the goal of maximizingmuscular gains against the preference for treatment convenience and stability
Background: Prenatal exposure to omega-3 polyunsaturated fatty acids (n-3 PUFAs) may influence immune development, but associations with allergic disorders in childhood remain inconsistent. Objective: To evaluate the association of maternal omega-3 exposure during pregnancy with childhood asthma, wheeze, eczema, and allergic nasal disease. Methods: This systematic review and exploratory meta-analysis included 13 independent study populations contributing 22 outcome-specific estimates. Prenatal dietary intake, biomarkers, fish consumption, and supplementation were considered. Random-effects models used restricted maximum likelihood (REML) estimation with modified Knapp-Hartung inference; pooled effects are presented as log odds ratios (logORs) with 95% confidence intervals (CIs).Results: For asthma (k = 5), pooled logOR was -0.240 (95% CI -0.444 to -0.036; p = 0.031; I² = 0.0%). For wheeze (k = 5), logOR was -0.071 (95% CI -0.176 to 0.035; p = 0.137; I² = 31.3%). For eczema (k = 7), logOR was -0.106 (95% CI -0.839 to 0.627; p = 0.736; I² = 78.4%). For allergic nasal disease (k = 5), logOR was -0.078 (95% CI -0.461 to 0.305; p = 0.602; I² = 72.8%). Conclusions: Higher maternal omega-3 exposure was associated with lower pooled odds of childhood asthma, whereas associations for the other outcomes were statistically inconclusive. Differences in exposure definitions, study designs, and allergy phenotypes limit causal interpretation.